The Seaver Center for Autism Research and Treatment Receives $2.78 Million Gift from the Beatrice and Samuel Seaver Foundation to Support Precision Medicine Research in Autism Spectrum Disorders
Trustees Hirschell E. Levine and John Cohen of the Beatrice and Samuel Seaver Foundation recently announced a $2.78 million gift to The Seaver Autism Center for Research and Treatment at Mount Sinai to support precision medicine research in autism spectrum disorders (ASD), including rare genetic causes of autism. This gift brings the Seaver Foundation’s support of the Center to $5 million for the year.
This funding will allow The Seaver Autism Center to enhance its focus on precision medicine, including expansion of research programs in ADNP syndrome, FOXP1 syndrome, DDX3X syndrome and SHANK3 syndrome. These rare genetic disorders provide unique windows into the causes of autism because biomarkers seen in rare genetic disorders can be used to stratify the patient population in idiopathic autism and create subgroups that, for example, may be more responsive to a particular treatment. Funding will also support the development of a drug discovery and development program, one of the first of its kind in the field of autism.
“The incredibly generous, ongoing support of the Seaver Foundation has been the cornerstone of the growth of the Center,” says Joseph D. Buxbaum, PhD, Director of The Seaver Autism Center. “The Center’s reputation as a leader in the field of autism research and treatment, coupled with the continuous, extraordinary support from the Seaver Foundation, make us well positioned to take these crucial next steps to help autism treatment forward.”
“Over the past 25 years, The Seaver Center has grown and become one of the leading autism programs in the world,” says Kenneth L. Davis, Chief Executive Officer and President of the Mount Sinai Health System and Founding Director of The Seaver Center. “Our discoveries, accomplishments, and success in obtaining federal funding have roots in Seaver Foundation support and we are profoundly grateful for their continued generosity.”
Founded in 1993 through a gift from the Beatrice and Samuel Seaver Foundation to The Mount Sinai Hospital to address the unmet need for autism research in New York City, The Seaver Autism Center is celebrating its 25th anniversary in 2018. At the time of its founding, there was minimal awareness and research, but the Seaver Foundation and Mount Sinai were willing to take on the challenge of establishing an autism research and treatment center from the start. With this shared goal, The Seaver Autism Center for Research and Treatment was born. This latest gift of support will enable the Center to push autism research and treatment forward to the next level.
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest integrated delivery system encompassing seven hospital campuses, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai's vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation.
The System includes approximately 6,600 primary and specialty care physicians; 10 joint-venture ambulatory surgery centers; more than 140 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools", aligned with a U.S. News & World Report's "Honor Roll" Hospital, No. 13 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 18 on U.S. News & World Report's "Honor Roll" of top U.S. hospitals; it is one of the nation's top 20 hospitals in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Geriatrics, Nephrology, and Neurology/Neurosurgery, and in the top 50 in four other specialties in the 2017-2018 "Best Hospitals" issue. Mount Sinai's Kravis Children's Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 12th nationally for Ophthalmology and 50th for Ear, Nose, and Throat, while Mount Sinai Beth Israel, Mount Sinai St. Luke's and Mount Sinai West are ranked regionally.